Search

DENV4 NS1 Antibody Patent US12606611B2 Granted to US Dept Health

The USPTO granted Patent No. US12606611B2 to the United States of America, as represented by the Secretary of the Department of Health & Human Services, covering antibodies that specifically bind to Dengue virus serotype 4 (DENV4) non-structural protein 1 (NS1). The patent includes 16 claims and names Elizabeth Anne Hunsperger and Tesfaye Gelanew Taye as inventors.